Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPα during oral cancer suppression

The Fibrotic Phenotype Induced by IGFBP-5 Is Regulated by MAPK Activation and Egr-1-Dependent and -Independent Mechanisms

(2009) Hidekata Yasuoka et al.   AMERICAN JOURNAL OF PATHOLOGY

RETRACTED: Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers

(2009) Sheeja T. Tharakan et al.   BIOCHEMICAL PHARMACOLOGY

Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1

(2008) H.-W. Chen et al.   CANCER RESEARCH

Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis

(2008) Seung Bae Rho et al.   CARCINOGENESIS

Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor  B by an AKT-Independent Pathway

(2008) D. Wang et al.   CLINICAL CANCER RESEARCH

Insulin-like growth factor binding protein-5 enhances the migration and differentiation of gingival epithelial cells

(2008) P.-S. Hung et al.   JOURNAL OF PERIODONTAL RESEARCH

Curcumin as “Curecumin”: From kitchen to clinic

(2007) Ajay Goel et al.   BIOCHEMICAL PHARMACOLOGY